The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Investors Count

1

Deal Terms

1

Bristol-Myers Squibb - HIV R&D Assets Funding, Bristol-Myers Squibb - HIV R&D Assets Valuation & Bristol-Myers Squibb - HIV R&D Assets Revenue

1 Fundings

Bristol-Myers Squibb - HIV R&D Assets's latest funding round was a Acquired Unit for on December 18, 2015.

Bristol-Myers Squibb - HIV R&D Assets's latest post-money valuation is from December 2015.

Sign up for a free trial to see Bristol-Myers Squibb - HIV R&D Assets's valuations in December 2015 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/18/2015

Acquired Unit

$99M

0

FY undefined

2

Date

12/18/2015

Round

Acquired Unit

Amount

Investors

Valuation

$99M

Revenue

0

FY undefined

Sources

2

Bristol-Myers Squibb - HIV R&D Assets Deal Terms

1 Deal Term

Bristol-Myers Squibb - HIV R&D Assets's deal structure is available for 1 funding round, including their Acquired Unit from December 18, 2015.

Round

Acquired Unit

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired Unit

$99M

$99M

$99M

$99M

Bristol-Myers Squibb - HIV R&D Assets Investors

1 Investors

Bristol-Myers Squibb - HIV R&D Assets has 1 investors. Viiv Healthcare invested in Bristol-Myers Squibb - HIV R&D Assets's Acquired Unit funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/18/2015

12/18/2015

1
Acquired Unit

Corporation

United Kingdom

First funding

12/18/2015

Last Funding

12/18/2015

Investor

Rounds

1
Acquired Unit

Board Seats

Type

Corporation

Location

United Kingdom

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.